Home | Cancers | Skin Cancer

Skin Cancer

Ratio of Certain Immune Cells to Tumor Burden Correlated With Outcome For Pembrolizumab-treated Patients With Melanoma

NEW YORK — Among patients with stage IV melanoma who were being treated with the immunotherapeutic pembrolizumab (Keytruda), the ratio of a ...

Low factor sunscreen can increase melanoma risk

Using low sun protection factor may increase the risk of melanoma. Cutaneous melanoma is one of the most rapidly increasing cancers in ...

Nanotechnology Supports Treatment of Malignant Melanoma

Changes in the genetic make-up of tissue samples can be detected quickly and easily using a new method based on nanotechnology. This report researchers from the Swiss Nanoscience Institute, the University of Basel and the University Hospital Basel in first clinical tests with genetic mutations in patients with malignant melanoma. The journal Nano Letters has published the study. ... Full story

Immune-Cell Population Predicts Immunotherapy Response in Melanoma

All Patients With High Levels of One Immune-Cell Type Responded to Treatment ... Full story

Combining Ipilimumab With Local Treatments Improved Survival for Patients With Melanoma

PHILADELPHIA — Among patients with melanoma, those who received both ipilimumab (Yervoy) and local peripheral treatments such as radiotherapy or electrochemotherapy had significantly prolonged overall survival compared with those who received only ipilimumab, according to a retrospective clinical study published in Cancer Immunology Research, a journal of the American Association for Cancer Research. ... Full story

Tel Aviv University Research Opens the "Black Box" of Malignant Melanoma

Study pinpoints when melanoma cells metastasize to the brain months before they develop into fatal tumors ... Full story

Student invention a shining example of sun safety

Two out of three Australians will develop skin cancer before turning 70, with research showing the majority of sun damage occurs during childhood and adolescence. ... Full story

UCLA study sheds light on how advanced melanoma resists treatment

Findings are a promising step toward developing improved treatments for the disease ... Full story

Molecular Diagnostics Separate Malignant from Benign Melanocytic Tumors

Jeong Hee Cho-Vega, M.D., Ph.D., a skin cancer expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues have shown that a relatively simple, multi-step molecular diagnostic algorithm can help determine whether rare, atypical spitzoid tumors are benign spitz nevi or malignant melanomas. This new protocol could ensure that patients receive the right therapies to match the severity of their tumors. The study was published in the journal Modern Pathology. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 162 | displaying: 1 - 10